PanTher Therapeutics, Inc.
Austin, TX · Founded 2014 · CIK 0001644045 · Medtech · Private
Localized drug delivery system that enables continuous high-dose chemotherapy exclusively at tumor sites
panthertx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $12M
- 9 Form D · Apr 2025
- 18 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 12
- 2 granted · 10 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $95,000 | |
| Private capital raised | Form D · SEC | $35,000 | |
| Private capital raised | Form D · SEC | $268,061 | |
| Private capital raised | Form D · SEC | $209,488 | |
| Private capital raised | Form D · SEC | $3,032,514 | |
| Private capital raised | Form D · SEC | $1,061,000 | |
| Private capital raised | Form D · SEC | $1,261,500 | |
| Private capital raised | Form D · SEC | $2,676,030 | |
| Private capital raised | Form D · SEC | $3,021,707 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 747 | Bay Labs, Inc. | — | — |
| 748 | Endoscopy Assist Devices LLC | — | — |
| 749 | NVE CORP. (FORMERLY NONVOLATILE ELECTRONICS, INC. | — | — |
| 750 | PanTher Therapeutics, Inc. | — | $12M |
| 751 | NESHER TECHNOLOGIES INC | — | — |
| 752 | BACKYARD BRAINS, INC. | — | — |
| 753 | Greppo Technologies LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Manish BhandariDirector
- MANISH BHANDARIDirector
- Elazer EdelmanDirector
- John EdwardsDirector
- Laura IndolfiDirector · Executive Officer
- LAURA INDOLFIDirector · Executive Officer
- D MackeyDirector
- Maria PalasisDirector
- MARIA PALASISDirector
- David TingDirector
- DAVID TINGDirector
- Daniel WildmanDirector
- Darshana ZaveriDirector
- DARSHANA ZAVERIDirector
Patents
- Methods Of Treating Pancreatic Cancerapplication
- Methods Of Treating Pancreatic Cancergranted
- Implantable And Biodegradable Drug Delivery Devices And Methods Of Use Thereofapplication
- Implantable And Biodegradable Drug Delivery Devices And Methods Of Use Thereofgranted
- Tissue Penetrating And Biodegradable Drug Delivery Devices And Methods Of Use Thereofapplication
- Methods Of Treating Pancreatic Cancerapplication
- Implantable And Biodegradable Drug Delivery Devices And Methods Of Use Thereofapplication
- Implantable And Biodegradable Drug Delivery Devices And Methods Of Use Thereofapplication
- Methods Of Treating Pancreatic Cancerapplication
- Tissue Penetrating And Biodegradable Drug Delivery Devices And Methods Of Use Thereofapplication
- Tissue Penetrating And Biodegradable Drug Delivery Devices And Methods Of Use Thereofapplication
- Implantable And Biodegradable Drug Delivery Devices And Methods Of Use Thereofapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.